All Articles

As utility grids strain and costs rise, companies are offering a new vision: an AI-powered home for energy independence. But can this technology truly deliver a smarter, more resilient future?

The value retailer's 2026 food drive reveals a sophisticated new model, blending national scale with local impact to redefine corporate philanthropy.

International runners are turning Japan's marathons into extended family holidays, blending sport with cultural exploration and boosting local economies.

Homes for Heroes Foundation's $2M in grants isn't just charity. It's the result of an integrated model where commerce directly fuels a critical social mission.

As Germany's football fever peaks, Dangbei is using deep Prime Day discounts to challenge the TV's dominance. Is this a simple sale or a strategic play to redefine home entertainment?

Heparin, a trusted blood thinner, can trigger a fatal immune reaction. A small biotech's novel drug is now taking the global stage with a targeted solution.

NTT DATA's landmark partnership with AI coding platform Cursor is more than a tech deal. It's a strategic bet on redefining enterprise modernization.

As McKesson prepares its August 5th earnings, all eyes are on its strategic overhaul. Will bold moves in oncology and tech deliver on profit promises?

Fintech firm Lili's new server connects AI to real-time banking data, promising to free accountants from manual tasks and elevate them to strategic advisors.

Enterprises are bleeding millions from expired certificates and weak encryption. A new platform aims to map this invisible risk, using AI to prepare for a post-quantum world.

Fetch Pet Insurance was just voted #1 by Newsweek readers. But behind the award lies a story of radical policy changes and a mission that could reshape the industry.

Aduro Clean Technologies secures a C$9.1M capital injection to scale its innovative water-based recycling. But is this a leap forward or a complex financial maneuver?

Mace Consult lands at #7 on ENR's prestigious list, backed by Goldman Sachs and over $1B in revenue. How are they using AI to deliver certainty on the world's largest projects?

Facing delisting, Virax Biolabs consolidates its shares in a bid to survive. This move buys time, but the real test lies in its innovative T-cell technology.

WiseTech Global's strategic certification of ShipDNA as a key service partner signals a major move to bolster support for its critical Transtream shipping platform.

Rising costs are driving a ‘Great Retirement Migration.’ We analyze the operational model of communities like Tellico Village, where tax policy and design intersect.

With a seasoned med-tech innovator at the helm, Picard Medical's SynCardia faces a pivotal moment. Can it expand its life-saving artificial heart monopoly?

A strategic partnership between IMU Biosciences and Waters Corp. aims to pair AI with advanced hardware, creating a high-definition map of our immune system.

Despite passing all resolutions, Novavax faces a reckoning as nearly half of shareholders reject its pay plan, amplifying activist investor Shah Capital's demands.

A Chinese firm's deal to sell AI painting robots in Africa is more than a sale; it's a blueprint for a new industrial era and a test of global competition.